High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas - Rationale for combination with radiotherapy

Acta Oncologica

Volumn 39, Issue 2, 2000, Pages 207-211

  Koukourakis, Michael I ^a,b   Koukouraki, Sofia ^a,b   Giatromanolaki, Alexandra ^b   Kakolyris, Stelios ^a   Georgoulias, Vassilis ^a   Velidaki, Antigoni ^a   Archimandritis, Spyridon ^c   Karkavitsas, Nikolaos N ^a  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b Tumour and Angiogenesis Research Group Iraklion   (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PENTETATE TECHNETIUM TC 99M;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SARCOMA;

EID: 0034065024     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600430789     Document Type: Article

References (24)

1. Gustafson P, Dreinhöfer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994; 65: 47-50.
2. Williard WC, Hajdu SI, Casper ES, Brennan MF. Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann Surg 1992; 215: 269-75.
3. (Anonymous). Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma meta-analysis collaboration. Lancet 1997; 350: 1647-54.
4. Pollack A, Zagars GK, Goswitz MS, Pollock RA, Feig BW, Pisters PW. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys 1998; 42: 563-72.
5. Kinsella TJ, Glatstein E. Clinical experience with intravenous radiosensitizers in unresectable sarcomas. Cancer 1987; 59: 908-15.
6. Martinez A, Goffinet DR, Donaldson SS, et al. Intra-arterial infusion of radiosensitizer (BUdR) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma. Int J Radiat Oncol Biol Phys 1985; 11: 123-1288.
7. Zambatis C, Skarlatos J, Koukourakis M, et al. High dose hypofractionated radiotherapy with concommitant 5-fluorouracil in the treatment of advanced sarcomas of the bone. A Pilot study. Sarcoma 1998; 2: 25-8.
8. Edmonson JH, Ryan LM, Blum RH, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993; 11: 1269-75.
9. Borden EC, Amato DA, Edmonson JH, Ritch PS, Shiraki M. Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas. Cancer 1990; 66: 862-7.
10. Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995; 13: 1537-45.
11. Bonner JA, Lawrence TS. Doxorubicin decreases the repair of radiation-induced DNA damage. Int J Radiat Biol 1990; 57: 55-64.
12. Sherman DM, Carabell SC, Belli JA, Hellman S. The effect of dose rate and adriamycin on the tolerance of thoracic radiation in mice. Int J Radiat Oncol Biol Phys 1982; 8: 45-51.
13. Gabizon A, Catane R, Uziely B, et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994; 54: 987-92.
14. Working PK, Newsman MS, Huang SK, Mayhew E, Vaage J, Lasic DD. Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in stealth® liposomes (Doxil®). J Liposom Res 1994; 4: 667-87.
15. Koukourakis MI, Koukouraki S, Giatromanolaki A, et al. Stealth liposomal doxorubicin (Caelyx) and conventionally fractionated radiotherapy in the treatment of locally advanced non-small cell lung and head and neck cancer. J Clin Oncol 1999, (in press)
16. World Health Organization. Handbook for reporting results of cancer treatment. Geneva: WHO Offset Publ, 1979: 48.
17. Lasic DD, Martin FJ, Gabizon A, et al. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1991; 1070: 187-92.
18. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988; 133: 95-109.
19. Stewart S, Harrington KJ. The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors. Oncology 1997; 10 (Suppl 11): 33-7.
20. Sakayama K, Masuno H, Miyazaki T, et al. Existence of lipoprotein lipase in human sarcomas and carcinomas. Jpn J Cancer Res 1994; 85: 515-21.
21. Cobbs CS, Brenman JE, Aldape KD, et al. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995; 15: 727-30.
22. Koukourakis MI, Giatromanolaki A, Kakolyris S, et al. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non small cell lung cancer. Impact on neoangiogenesis and survival. Br J Cancer 1998; 77: 1696-703.
23. Harrington KJ, Rowlinson-Busza G, Uster PS, et al. Stealth® liposome encapsulated doxorubicin (SLED) and iododeoxyuridine (SLIIUDR) as radiation sensitizers in head and neck squamous cell cancer xenograft tumors (HNSCCXT). Proc Am Soc Clin Oncol 1998 (abstr 881).
24. Hug EB, Fitzek MM, Liebsch NJ, Munzenrider JE. Locally challenging osteo and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1995; 31: 467-76.